Abstract
We report an unusual case of a patient with two combined X-linked diseases, severe hemophilia A (HA) and Duchenne muscular dystrophy (DMD), of which only HA was hereditary. There was no family history of muscular dystrophy. Genetic analysis revealed that HA was caused by the hereditary coagulation factor VIII (F8) intron 22 inversion (distal/type I inversion), whereas DMD was caused by a de novo deletion in the dystrophin gene. This is the first report of a patient with two severe X-linked diseases, of which only HA was hereditary. Despite the fact that the probability of acquiring two X-linked abnormalities, one hereditary and one de novo, is extremely low, the emergence of such cases indicates that genetic testing for distinct X-linked diseases could be of importance in patients with hereditary hemophilia.
Abbreviations
- APCC:
-
Activated prothrombin complex concentrates
- CK:
-
Creatine kinase
- DMD:
-
Duchenne muscular dystrophy
- DMD gene:
-
Dystrophin gene
- HA:
-
Hemophilia A
- PCC:
-
Prothrombin complex concentrates
References
Rossetti LC, Radic CP, Abelleyro MM, Larripa IB, De Brasi CD. Eighteen years of molecular genotyping the hemophilia inversion hotspot: from southern blot to inverse shifting-PCR. Int J Mol Sci. 2011;12:7271–85.
Antonarakis SE, Rossiter JP, Young M, Horst J, de Moerloose P, Sommer SS, et al. Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood. 1995;86:2206–12.
Lakich D, Kazazian HH Jr, Antonarakis SE, Gitschier J. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet. 1993;5:236–41.
del Gaudio D, Yang Y, Boggs BA, Schmitt ES, Lee JA, Sahoo T, et al. Molecular diagnosis of Duchenne/Becker muscular dystrophy: enhanced detection of dystrophin gene rearrangements by oligonucleotide array-comparative genomic hybridization. Hum Mutat. 2008;29:1100–7.
Oshima J, Magner DB, Lee JA, Breman AM, Schmitt ES, White LD, et al. Regional genomic instability predisposes to complex dystrophin gene rearrangements. Hum Genet. 2009;126:411–23.
Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev. 2002;82:291–329.
Beggs AH, Koenig M, Boyce FM, Kunkel LM. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet. 1990;86:45–8.
Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 1988;16:11141–56.
Zhang AH, Skupsky J, Scott DW. Factor VIII inhibitors: risk factors and methods for prevention and immune modulation. Clin Rev Allergy Immunol. 2009;37:114–24.
Strauss T, Lubetsky A, Ravid B, Bashari D, Luboshitz J, Lalezari S, et al. Recombinant factor concentrates may increase inhibitor development: a single centre cohort study. Haemophilia. 2011;17:625–9.
Hay CR. Why do inhibitors arise in patients with haemophilia A? Br J Haematol. 1999;105:584–90.
Prior TW, Bridgeman SJ. Experience and strategy for the molecular testing of Duchenne muscular dystrophy. J Mol Diagn. 2005;7:317–26.
Konagaya M, Takayanagi T, Kamiya T, Takamatsu S. Genetic linkage study of Duchenne muscular dystrophy and hemophilia A. Neurology. 1982;32:1046–9.
Gokce M, Gumruk F, Haliloglu G, Serdaroglu E, Caglayan H. Double trouble: Duchenne muscular dystrophy and hemophilia. Pediatr Blood Cancer. 2013;60:525.
Acknowledgments
This work was supported by the grant J1-8762 provided by the Slovenian Research Agency to RK and LS. The authors would like to thank Dr. Gian Antonio Danieli and Dr. Maurizio Rosa for their contributions to molecular analysis of DMD gene. We also thank Dr. Jane Gitschier, Howard Hughes Medical Institute, University of California, San Francisco, for kindly supplying the plasmid p482.6 probe.
Ethical standard
The study was approved by the National Medical Ethics Committee of the Republic of Slovenia. The patient and the family members were informed about the purpose, procedures, meaning, limitations and possible consequences of these genetic analyses by the treating physician and signed consent was obtained.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
About this article
Cite this article
Strmecki, L., Hudler, P., Benedik-Dolničar, M. et al. De novo mutation in DMD gene in a patient with combined hemophilia A and Duchenne muscular dystrophy. Int J Hematol 99, 184–187 (2014). https://doi.org/10.1007/s12185-013-1488-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-013-1488-4